January 23, 2024

#5 - Jason Foster: Driving Global Access to Life-Saving Therapies

Listen and subscribe on your favorite platform

This podcast episode features a conversation with Jason Foster, CEO of Ori Biotech, who discussed his varied career and insights into the biotech industry. Foster’s journey began in politics and healthcare policy in Washington, D.C., where he recognized the private sector’s crucial role in healthcare innovation. This realization spurred him to attend business school, leading to a significant role in a pharmaceutical company. His work there, marked by substantial growth, eventually took him to London to oversee European operations.

Foster’s career pivot to startups and healthcare investments reflects his passion for innovative healthcare solutions. He emphasizes the importance of assembling a strong team and the ability to solve complex problems in the startup environment. This approach is evident in his leadership at Ori Biotech, a company focused on revolutionizing cell and gene therapy manufacturing.

At Ori Biotech, Foster addresses the challenges of making advanced therapies accessible and affordable. He discusses the technological innovations and manufacturing strategies employed by Ori to streamline the production of these therapies. His vision is to democratize cell and gene therapies, making them available to a broader patient population.

The interview also delves into the broader implications of Ori Biotech’s work in the healthcare sector. Foster highlights the potential impact of their technology in transforming patient outcomes and reducing healthcare costs. He underscores the significance of collaboration between the private sector, academia, and regulatory bodies in advancing healthcare innovation.

About this Guest

Jason Foster

Jason is a dynamic leader with over 20 years of experience in the healthcare and technology sectors across the US, UK, and Europe. As the Chief Executive Officer of Ori Biotech, he spearheads the company’s efforts in revolutionizing cell and gene therapy manufacturing technology. Through digital transformation, Ori Biotech’s technology is automating and standardizing cell and gene therapy manufacturing. As a result, their system facilitates an innovative progression from pre-clinical stages to large-scale commercial production for therapy developers. The platform’s advanced hardware, intuitive software, and detailed analytical tools, is designed to boost production efficiency and reliability, all while simultaneously reducing costs. This advancement is pivotal in scaling up the production of critical therapies, facilitating their accessibility to a broader range of patients globally. Jason is also the host of the Ori Spotlight Podcast.

Explore Other Episodes

#8 – Aaron Emerson: Never Walking the Grey

Aaron is the Chief Executive Officer at CEGA Innovations located in Sioux Falls, SD. Before co founding CEGA, Aaron honed his expertise as a litigation attorney, specializing in complex commercial disputes and risk advisement. His rich background also extends into the academic realm, having delved into neuroscience at the University of South Dakota and Creighton University School of Medicine, kidney ischemia research at University Physicians, and cardiovascular studies at the University of Nebraska Medical Center.

Read More »

#16 – Sharing the Inside View: Reflections from the USD Discovery District Team

Ryan Oines leads the USD Discovery District as President and CEO, driving economic growth through biotech and life sciences innovation. With over 25 years of experience launching startups and securing capital, he oversees a $314M development plan for 26 buildings, fostering 2,800 jobs. His strategic vision strengthens public-private partnerships, positioning South Dakota as a hub for research and commercialization.

Marc Niamba advances the USD Discovery District’s mission to pioneer life sciences innovation. As a key contributor to GreenLight Bionics, he leverages virtual reality to enhance physical therapy solutions, earning recognition in the 2021 Governor’s Giant Vision Competition. His expertise in computer science and artificial intelligence has enabled him to create internal management and tenant recruitment tools.

Tung Nguyen amplifies the USD Discovery District’s vision of innovation and economic impact. With a background in mechanical engineering and regulatory strategy, he crafts data-driven campaigns to attract biotech tenants and showcase the District’s $23MM funded private public partnership. Nguyen’s strategic storytelling connects academia, industry, and government, driving engagement and growth across South Dakota’s life sciences ecosystem.

Read More »

#13 – Wassim Laroussi: Exploring Public Biotech Stocks

Wassim Laroussi is the founder and creator of The Biotech Investor Youtube channel.

The Biotech Investor is dedicated to exploring the biotechnology sector, with a focus on small to medium-sized companies developing innovative therapies and medications. The channel provides biweekly financial analyses of promising biotech stocks, offering insights into their potential impact on healthcare. Each episode covers recent developments and key factors for investors to consider. Aimed at both experienced and new investors, The Biotech Investor delivers clear, detailed information to support informed decision-making in the evolving world of biotechnology.

Read More »

Join our newsletter for regular updates on the podcast, USD Discovery District, and medtech and life science related insights.

By submitting your email to subscribe, you agree to our Privacy Policy.

Proudly Sponsored By